CardiaCare Raises Seed Funding for Cardiac Clinical Studies
Rehovot, Israel, September 18, 2026 CardiaCare, a medical device company developing wearable technology for cardiac arrhythmias, has announced the...
Neuromodulation
Advertisement
SetPoint Medical Expands RA Neuroimmune Therapy in Oregon
Valencia, California, USA, September 16, 2026 SetPoint Medical announced that Oregon Health & Science University (OHSU) has become the...
ReEmerge Raises $37M to Advance Brain Injury Technology
Boston, Massachusetts, U.S., September 15, 2026 ReEmerge, Inc. has emerged from stealth with an oversubscribed $37 million Series A...
NRx Pharmaceuticals Deploys Robotic TMS Across HOPE Clinics
WILMINGTON, Del. — September 11, 2026 NRx Pharmaceuticals, Inc. announced that its subsidiary HOPE Therapeutics has begun training and...
Nyxoah Begins U.S. BREATHE Study With First Genio Implant
Mont-Saint-Guibert, Belgium — September 7, 2026 Nyxoah announced that the first patient has been implanted in BREATHE, its U.S....
Advertisements
ONWARD Medical Begins EIGER Study With First ARC-IM Implant
Eindhoven, Netherlands, September 3, 2026 ONWARD Medical announced the first implant in the new EIGER clinical feasibility study, evaluating...
Autonomix Medical Expands U.S. Patent Protection for Neuromodulation
THE WOODLANDS, Texas, Aug. 26, 2026 Autonomix Medical, Inc. has expanded its intellectual property portfolio with the issuance of...
Datasea Lists NeuroVibe as FDA Class II Biofeedback Device
Beijing, China, August,11, 2026 Datasea Intelligent Technology Ltd. has announced that its variable interest entity, Shuhai Jingwei (Shenzhen) Information...
BlueWind Medical Wins FDA Clearance for Revi Extend Implant
Salt Lake City, Utah, August 6, 2026 BlueWind Medical, Ltd. has received U.S. Food and Drug Administration (FDA) 510(k)...
Integer to Be Acquired by KKR in $5.7 Billion Deal
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
Advertisement
